 The primary objective of this study is to evaluate the analgesic efficacy, on Post-Operative Day POD 1, of DEX-IN compared with placebo, using the summed pain intensity difference over the first 48 hours SPID48 in subjects with acute moderate to severe pain following unilateral bunionectomy. 